background image

Paid Clinical Trials Iowa

Discover 683 paid clinical trials in Iowa. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1
Active & ResponsiveNew

Use of In-Home Non-Stress Monitoring Device for Fetal Monitoring: A Nonsignificant Risk (NSR) Device Study

for
Pregnancy, Fetal Monitoring
Location: West Des Moines IA, Champaign IL, Wilmington NC
Sponsor: Nestmedic Spolka Akcyjna

Sex: Female

Age: 22+

Code: NCT07223996

Recruiting
Active & ResponsiveNew

A Study to Evaluate the Safety and Efficacy of CD388 for Prevention of Influenza

for
Influenza
Location: West Des Moines IA, Omaha NE, Mankato MN, Fremont NE,
Sponsor: Cidara Therapeutics Inc.

Sex: All

Age: 12+

Code: NCT07159763

Phase3, Recruiting
Active & ResponsiveNew

Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant

for
Acute Biphenotypic Leukemia, Acute Leukemia,
Location: Iowa City IA, Cleveland OH, Pittsburgh PA,
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 0 - 26

Code: NCT03779854

Phase2, Recruiting
Active & ResponsiveNew

A Study to Assess the Safety and Efficacy of LB-P8 in Patients With PSC

for
Primary Sclerosing Cholangitis (PSC)
Location: Iowa City IA, Nashville TN, Baltimore MD, Seattle WA
Sponsor: LISCure Biosciences

Sex: All

Age: 18 - 70+

Code: NCT06699121

Phase2, Recruiting
Active & Responsive

A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors

for
Cervical Cancer,
Location: Iowa City IA, Nashville TN, Hamilton, Houston TX,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT04895709

Phase1, Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)

for
Pheochromocytoma/Paraganglioma, Pancreatic Neuroendocrine Tumor,
Location: Iowa City IA, Chicago IL, Ann Arbor MI, Nashville TN,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 12+

Code: NCT04924075

Phase2, Recruiting
Active & Responsive

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Iowa City IA, Saint Louis Park MN, Madison WI,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06136559

Phase3, Recruiting
Active & Responsive

The Heartland Study

for
Pregnancy Related, Pregnancy Complications, Birth Defect,
Location: Iowa City IA, Marshfield WI, Indianapolis IN
Sponsor: Heartland Health Research Alliance

Sex: Female

Age: 18+

Code: NCT05492708

Recruiting
Active & Responsive

Genetic Epidemiology of Rotator Cuff Tears: The cuffGEN Study

for
Rotator Cuff Tears
Location: Iowa City IA, Ann Arbor MI, Dallas TX
Sponsor: University of Michigan

Sex: All

Age: 40 - 70+

Code: NCT04831164

Recruiting
Active & Responsive

A Study to Evaluate the Efficacy, Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Satralizumab in Participants With Anti-N-methyl-D-aspartic Acid Receptor (NMDAR) or Anti-leucine-rich Glioma-inactivated 1 (LGI1) Encephalitis

for
NMDAR Autoimmune Encephalitis, LGI1 Autoimmune Encephalitis
Location: Iowa City IA, Rochester MN, Milwaukee WI, Cleveland OH,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 12+

Code: NCT05503264

Phase3, Recruiting

Popular cities in Iowa

Offering a distinguished healthcare infrastructure and top class research institutions, Iowa has emerged as a significant base for a wide range of clinical trials. Major institutions such as the University of Iowa Hospitals and Clinics and the Holden Comprehensive Cancer Center are at the forefront of these studies, driving advancements in fields like oncology, cardiovascular research, and more. Iowa’s commitment to medical innovation and its growing network of research centers make it a developing hub in cutting-edge clinical trials.

Why choose Iowa for clinical trials?

Common conditions studied in Iowa

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Iowa